News & Updates

Both sham manual acupuncture (MA) and sham electroacupuncture (EA) result in better symptoms and quality of life (QoL) scores among individuals with functional dyspepsia (FD) without affecting objective outcomes, a study has found. This finding underscores the importance of sham controls in acupuncture therapy clinical trials.

Ustekinumab is well tolerated and proves to be effective in the second-line treatment of patients with Crohn’s disease, according to real-world data from the Cross Pennine II study. Furthermore, while clinical remission appears to occur sooner with ustekinumab than with vedolizumab, the two drugs perform comparably at maintaining remission over 12 months.

Administration rates of antiviral therapy remain low among treatment-eligible patients with chronic hepatitis B virus (CHB) and among CHB patients without human immunodeficiency virus (HIV), reveals a recent study.

Daily use of aspirin reduces the risk of incident hepatocellular carcinoma (HCC), while the combination of daily aspirin use and statin results in a lower incidence of HCC, which suggests a beneficial interaction, according to a study. In addition, no excess oesophageal variceal haemorrhage (VH) is seen among daily aspirin users compared with nonusers.

Anti-tumour necrosis factor (TNF) treatment appears to be less effective in elderly-onset inflammatory bowel disease, a recent study has found.

Patients who use cannabis to treat nausea normally experience relief within a relatively short period of time, a recent study has shown. However, the level of antiemetic effect varies with the characteristics of the cannabis products consumed in vivo.

In patients with older-onset ulcerative colitis (UC), treatment with intravenous (IV) steroids appears to be less effective and is associated with higher risks of surgery and adverse events relative to patients with younger-onset disease, a study has found.